Related Experiment Video
Updated: Sep 17, 2025

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
Enhanced Intracellular Delivery by Twisted CC-Loop Conformation in Cyclic Cell-Penetrating Peptides.
Qipeng Yan1,2, Xingyue Jiang1,2, Wei Xie1,2
1Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, School of Biomedical Sciences, Hunan University, Changsha, Hunan 410082, China.
Cyclic cell-penetrating peptides (CPPs) improve drug delivery by enhancing cellular uptake. A novel cyclic CPP, Y2-13-OX, demonstrated superior delivery of siRNA and other molecules due to its unique CC-loop structure.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Delivery Systems
Background:
- Biological drugs offer therapeutic potential but face challenges with cellular uptake.
- Cell-penetrating peptides (CPPs) are investigated to enhance the delivery of biomacromolecules.
- Optimizing CPP structure is crucial for improving delivery efficiency.
Purpose of the Study:
- To design and evaluate novel cyclic CPPs for enhanced cellular delivery.
- To investigate the structural basis for improved membrane penetration of cyclic CPPs.
- To demonstrate the utility of a novel cyclic CPP for delivering therapeutic payloads like siRNA.
Main Methods:
- Synthesis of three cyclic CPPs with varying ring sizes via disulfide bond formation.
- Assessment of membrane penetration and delivery efficiency using siRNA, GFP, and plasmids.
- Conformational analysis using computational methods to understand structure-activity relationships.
Main Results:
- The cyclic peptide Y2-13-OX adopted a distinct twisted CC-loop conformation.
- Y2-13-OX exhibited enhanced membrane penetration compared to linear and other cyclic CPPs.
- Y2-13-OX efficiently delivered functional siRNA targeting METTL3, achieving significant knockdown.
Conclusions:
- A novel cyclic CPP conformation (CC-loop) enhances therapeutic delivery efficiency.
- Y2-13-OX represents a promising platform for delivering nucleic acids and other biological drugs.
- This study provides new insights into CPP design for advanced drug transport strategies.
Related Concept Videos
Insertion of Single-pass Transmembrane Proteins in the RER
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Clathrin Coated Vesicles
Cotranslational Protein Translocation
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...

